Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial

8 April 2024 (08:30 - 09:15)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Andreas Rillig

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

7 More presentations in this session

Presentation thumbnail

Effectiveness of photoplethysmography-based rhythm monitoring after atrial fibrillation ablation using a smartphone application

Doctor H. Gruwez (Leuven, BE)

Abstract Slides Video

Presentation thumbnail

Predicting bleeding risk in frail older patients with atrial fibrillation using data from the FRAIL-AF trial

Doctor S. van Doorn (Utrecht, NL)

Abstract Slides Video

Presentation thumbnail

Management of edoxaban therapy in patients undergoing emergency/urgent procedures: a subanalysis of the global, prospective, observational, multinational EMIT-AF/VTE programme

Professor C. Von Heymann (Berlin, DE)

Abstract Slides Video

Presentation thumbnail

Impact of different dose reduction criteria on dose assignment of current DOACs and related outcomes: an analysis from 4-year data of the ETNA-AF Europe programme

Assistant Professor I. Diemberger (Bologna, IT)

Abstract Slides Video

Presentation thumbnail

Difference between cryoballoon and radiofrequency ablations for atrial fibrillation based on electroanatomical mechanisms

Doctor M. Kim (Yongin, KR)

Abstract Slides Video

Access the full session

Session thumbnail

Atrial fibrillation: treatment 1

The Event

Event poster

EHRA 2024

8 April 2024 08:30 CET

You may be interested in

Congress Presentation

Early rhythm control: impact on patient outcome

Congress Session

Late-Breaking Science: ablation and drug therapy

Congress Presentation

Early rhythm control: five years of improving outcomes for patients with atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources